Although the rate of drug list price increases has slowed in the last decade, the average launch price for a brand name drug entering the market has skyrocketed, according to a new report from drug research firm 46brooklyn.
Pharmacy
The FDA approved Eli Lilly's new migraine drug, Reyvow, making it the drugmaker's second migraine drug approval this year.
Sun Pharmaceuticals, one of the world's largest generic drugmakers, is accused of distributing samples of medicines in Washington state without the necessary license for more than two years, according to STAT.
House progressives have several changes they want to make to House Speaker Nancy Pelosi's drug-pricing legislation, according to STAT.
Though the FDA has said it will approve more generic drugs as a strategy to increase competition and combat drug shortages, a study published by JAMA Network Open found that the number of generic approvals has remained steady.
Advertisement
Merck plans to use a cloud-based software platform to better predict and prevent drug shortages, according to The Wall Street Journal.
A survey released Oct. 15 by healthcare legal and consulting group Manatt Health details how the 340B Drug Pricing Program works alongside Medicaid in all 50 states.
A Swiss newspaper reported that the U.S. is considering placing tariffs on exports of pharmaceutical goods from Switzerland, according to Endpoints News.
A critical chemotherapy medication that serves is a primary treatment for most childhood cancers has become increasingly scarce, according to The New York Times.
In the third quarter of 2019, 125 drugs increased in price by an average of 6.7 percent, according to a new quarterly report from drug savings website GoodRx.